Stocks · Health care · Pharmaceutical Preparations

CytomX Therapeutics, Inc.

CTMX Clue Score50
United States Fiscal year ends December CIK 0001501989 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Sean A. McCarthy
26 Mar 2024
CEO
Exercised, kept
109,768
$1.57
$172.87K
Sean A. McCarthy
19 May 2023
CEO
Exercised, kept
16,535
$1.57
$26.04K
Sean A. McCarthy
9 May 2022
President and CEO
Exercised, kept
24,189
$0.95
$22.86K
Sean A. McCarthy
9 May 2022
President and CEO
Exercised, kept
66,742
$0.95
$63.07K
Sean A. McCarthy
11 Aug 2021
President and CEO
Exercised, kept
92,113
$1.13
$104.45K
Sean A. McCarthy
14 Jun 2021
President and CEO
Exercised, kept
10
$0.95
$9.45
Sean A. McCarthy
14 Jun 2021
President and CEO
Exercised, kept
30
$1.13
$34.02
Sean A. McCarthy
23 Dec 2020
President and CEO
Exercised, kept
100,000
$1.13
$113.39K
Sean A. McCarthy
21 Sep 2020
President and CEO
Exercised, kept
20,500
$6.61
$135.60K
Rachel Humphrey
15 Dec 2017
Chief Medical Officer
Exercised, kept
15,117
$6.61
$99.99K
William Michael Kavanaugh
8 Dec 2017
CSO, Head Res.&Non-Clin. Dev.
Exercised, kept
5,130
$1.57
$8.08K
II Robert C. Goeltz
12 May 2017
Chief Financial Officer
Exercised, kept
9,987
$6.61
$66.06K
II Robert C. Goeltz
12 May 2017
Chief Financial Officer
Exercised, kept
9,980
$4.47
$44.64K
II Robert C. Goeltz
10 Apr 2017
Chief Financial Officer
Exercised, kept
3,000
$4.47
$13.42K
II Robert C. Goeltz
9 Mar 2017
Chief Financial Officer
Exercised, kept
2,500
$4.47
$11.18K
Rachel Humphrey
28 Dec 2016
Chief Medical Officer
Exercised, kept
15,117
$6.61
$99.99K

What was left out

Form 4 filings counted 311
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 14
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 53
Sales at will 91
Transactions with no price 0
Shares from compensation/vesting 8,432,272
Sales filed before the plan box existed 59
History held since 9 Oct 2015